Form 4 for KTTA Pasithea Therapeutics Corp.
Accepted 2025-05-14 00:00:00 ET · period of report 2025-05-12 · accession 0001213900-25-043621 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-14 | 2025-05-12 | KTTA | Marques Tiago | CEO, Dir | S - Sale | $0.83 | -960 | 40.0K | -2% | -$796.80 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-12 | S | D | 960 | $0.83 | 40,001 | D | — | — | (F1) The Reporting Person previously held 960 shares of Common Stock of the Issuer in a foreign brokerage account that was recently wound down. As a result, the foreign broker automatically liquidated the Reportion Person's account on May 12, 2025 by selling the 960 shares of Common Stock of the Issuer on a non-discretionary basis. |